Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

To the editor, Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases that are known to have profoundly negative effects on patient's quality of life.1 The majority of AD patients can be controlled with topical corticosteroids, but those with insufficient responses or who cannot reduce the potency/frequency of topical steroids to acceptable levels, will require treatment with systemic...